![Jean Franchi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean Franchi
Directeur Financier/CFO chez
DISC MEDICINE, INC.
Fortune : 161 261 $ au 30/09/2026
Profil
Ms. Jean M.
Franchi is a Chief Financial Officer & Treasurer at Disc Medicine, Inc., a Chief Financial Officer at Disc Medicine Opco, Inc. and an Independent Director at Biodesix, Inc. She is on the Board of Directors at Biodesix, Inc. and VectorY BV.
Ms. Franchi was previously employed as a Member-Supervisory Board by Dynacure SA, a Chief Financial Officer, Secretary & Treasurer by Replimune Group, Inc., an Independent Non-Executive Director by Visioneering Technologies, Inc., a CFO, Treasurer & Principal Accounting Officer by Merrimack Pharmaceuticals, Inc., an Independent Director by Biophytis SA, a Chief Financial Officer, Secretary & Treasurer by Dimension Therapeutics, Inc., a Chief Financial Officer by Good Start Genetics, Inc., a Controller & Senior VP-Corporate Finance by Genzyme Corp., a Senior Vice President-Corporate Finance by Sanofi-Aventis SA, a Senior Financial Analyst by bioMérieux, Inc., and a Manager-Sales Analysis by Wyeth LLC.
She also served on the board at International Institute of New England, Inc. and Flamingo Therapeutics BV.
She received her undergraduate degree from Hofstra University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIODESIX, INC. 0,07 % | 04/03/2026 | 5 406 ( 0,07 % ) | 161 261 $ | 30/09/2026 |
DISC MEDICINE, INC. -.--% | 22/04/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Postes actifs de Jean Franchi
| Sociétés | Poste | Début |
|---|---|---|
| BIODESIX, INC. | Directeur/Membre du Conseil | 01/04/2020 |
| DISC MEDICINE, INC. | Directeur Financier/CFO | 07/02/2024 |
VectorY BV
 VectorY BV BiotechnologyHealth Technology Develops vectorized antibody treatments for people with neurodegenerative diseases | Directeur/Membre du Conseil | - |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Directeur Financier/CFO | 01/02/2024 |
Anciens postes connus de Jean Franchi
| Sociétés | Poste | Fin |
|---|---|---|
| REPLIMUNE GROUP, INC. | Directeur Financier/CFO | 02/06/2023 |
| VISG TECHUNSP GDR | Directeur/Membre du Conseil | 19/12/2022 |
| BIOPHYTIS S.A. | Directeur/Membre du Conseil | 07/07/2021 |
| MERRIMACK PHARMACEUTICALS | Directeur Financier/CFO | 28/06/2019 |
International Institute of New England, Inc.
 International Institute of New England, Inc. Services to the Health IndustryHealth Services Operates charitable organization for refugees and immigrants | Directeur/Membre du Conseil | 01/01/2019 |
Formation de Jean Franchi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Biodesix, Inc.
 Biodesix, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic research and clinical trial testing services & engages in discovery, development and commercialization of therapeutics | Health Services |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Hofstra University
 Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute of New England, Inc.
International Institute of New England, Inc. Services to the Health IndustryHealth Services Operates charitable organization for refugees and immigrants | Health Services |
bioMérieux, Inc.
 bioMérieux, Inc. Medical SpecialtiesHealth Technology Develops in-vitro diagnostics solutions | Health Technology |
Biophytis SA
 Biophytis SA Pharmaceuticals: OtherHealth Technology Develops and markets dietary supplements and ingredients for functional food based on tropical plants | Health Technology |
Visioneering Technologies, Inc.
 Visioneering Technologies, Inc. Medical SpecialtiesHealth Technology Designs and markets contact lenses | Health Technology |
Good Start Genetics, Inc.
 Good Start Genetics, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostics services | Health Services |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for rare diseases | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Develops novel therapies to transform the lives of patients | Health Services |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Commercial Services |
VectorY BV
VectorY BV BiotechnologyHealth Technology Develops vectorized antibody treatments for people with neurodegenerative diseases | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
